Cleared Traditional

ClearCalc Model RADCA V2 (K220582) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K220582 · Radformation, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2022
Decision
174d
Days
Class 2
Risk

K220582 is an FDA 510(k) clearance for the ClearCalc Model RADCA V2. Classified as System, Planning, Radiation Therapy Treatment (product code MUJ), Class II - Special Controls.

Submitted by Radformation, Inc. (New York, US). The FDA issued a Cleared decision on August 22, 2022 after a review of 174 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Radformation, Inc. devices

Submission Details

510(k) Number K220582 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 01, 2022
Decision Date August 22, 2022
Days to Decision 174 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
67d slower than avg
Panel avg: 107d · This submission: 174d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MUJ System, Planning, Radiation Therapy Treatment
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - MUJ System, Planning, Radiation Therapy Treatment

All 113
Devices cleared under the same product code (MUJ) and FDA review panel - the closest regulatory comparables to K220582.
Oncospace
K222803 · Oncospace, Inc. · Feb 2023
syngo.via RT Image Suite
K220783 · Siemens Medical Solutions USA, Inc. · Sep 2022
MRI Planner
K211841 · Spectronic Medical AB · Aug 2022
Monaco RTP System
K213787 · Elekta Solutions AB · May 2022
RayStation 11B
K220141 · RaySearch Laboratories AB (PUBL) · Apr 2022
INT Contour
K212274 · Carina Medical, LLC · Apr 2022